Maria Àngels Ortiz

13PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Innate immunityRespiratory diseasesMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1.

|Mar 01, 2026
Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial).

Aida Piedra, Albert Guinart-Cuadra, Sergio Martínez-Recio

|Oct 29, 2025
Non-Competitive Binding of Isatuximab and Daratumumab to CD38: Implications for Targeted Therapy in Multiple Myeloma.

Rubén Osuna-Gómez, Jordi López-Pardo, Maria Mulet

|Sep 13, 2025
Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis.

Elisabet Cantó, María Elena Del Prado, Eva Vilarrasa

|May 13, 2025
Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis.

Carlos Zamora, Cesar Diaz-Torne, Maria Angels Ortiz

|Nov 27, 2024
Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics.

Luca Laghi, Maria Àngels Ortiz, Giacomo Rossi

Pageof 3

Frequent Collaborators

10 joint publications

Silvia Vidal

7 joint publications

Maria Mulet

6 joint publications

Hector Corominas

6 joint publications

Rubén Osuna-Gómez